Evaluation of an Intravenous-Endovascular Strategy in Patients with Acute Proximal Middle Cerebral Artery Occlusion

References

1. 1.↵
   1. Bluhmki E,
   2. Chamorro A,
   3. Machnig T,
   4. et al

   . Stroke treatment with alteplase given 3.0–4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomized controlled trial. Lancet Neurol 2009;8:1095–102

   CrossRefPubMedWeb of Science
2. 2.↵
   1. del Zoppo GJ,
   2. Poeck K,
   3. Pessin MS,
   4. et al

   . Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78–86

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Bhatia R,
   2. Hill MD,
   3. Shobha N,
   4. et al

   . Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010;41:2254–58

   Abstract/FREE Full Text
4. 4.↵
   1. Furlan A,
   2. Higashida R,
   3. Wechsler L,
   4. et al

   . Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial—Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Mattle HP,
   2. Arnold M,
   3. Georgiadis D,
   4. et al

   . Comparison of intra-arterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008;39:379–83

   Abstract/FREE Full Text
6. 6.↵
   1. Sekoranja L,
   2. Loulidi J,
   3. Yilmaz H,
   4. et al

   . Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography-guided pilot study. Stroke 2006;37:1805–09

   Abstract/FREE Full Text
7. 7.↵
   1. Rubiera M,
   2. Ribo M,
   3. Pagola J,
   4. et al

   . Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in a nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study. Stroke 2011;42:993–97

   Abstract/FREE Full Text
8. 8.↵
   1. Becktepe JS,
   2. You SJ,
   3. Berkefeld J,
   4. et al

   . Clinical outcome after mechanical recanalization as mono- or adjunctive therapy in acute stroke: importance of time to recanalization. Cerebrovasc Dis 2011;32:211–18

   CrossRefPubMed
9. 9.↵
   1. Mazighi M,
   2. Serfaty JM,
   3. Labreuche J,
   4. et al

   . Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE) study: a prospective cohort study. Lancet Neurol 2009;8:802–09

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Shi ZS,
    2. Loh Y,
    3. Walker G,
    4. et al

    . Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients: revascularization and outcomes stratified by the site of arterial occlusions. Stroke 2010;41:1185–92

    Abstract/FREE Full Text
11. 11.↵
    1. Sugiura S,
    2. Iwaisako K,
    3. Toyota S,
    4. et al

    . Simultaneous treatment with intravenous recombinant tissue plasminogen activator and endovascular therapy for acute ischemic stroke within 3 hours of onset. AJNR Am J Neuroradiol 2008;29:1061–66

    Abstract/FREE Full Text
12. 12.↵
    Tissue plasminogen activator for acute ischemic stroke: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581–87

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Costalat V,
    2. Machi P,
    3. Lobotesis K,
    4. et al

    . Rescue, combined, and stand-alone thrombectomy in the management of large vessel occlusion stroke using the Solitaire device: a prospective 50-patient single-center study—timing, safety, and efficacy. Stroke 2011;42:1929–35

    Abstract/FREE Full Text
14. 14.↵
    1. Nezu T,
    2. Koga M,
    3. Kimura K,
    4. et al

    . Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA registry. Neurology 2010;75:555–61

    CrossRef
15. 15.↵
    1. Higashida RT,
    2. Furlan AJ,
    3. Roberts H,
    4. et al.

    , Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:109–37

    CrossRef
16. 16.↵
    The IMS II Trial Investigators. The interventional management of stroke (IMS) II study. Stroke 2007;38:2127–35

    Abstract/FREE Full Text
17. 17.↵
    1. Nogueira RG,
    2. Liebeskind DS,
    3. Sung G,
    4. et al.

    , for the Multi MERCI Writing Committee. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI trials. Stroke 2009;40:3777–83

    Abstract/FREE Full Text
18. 18.↵
    Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761–68

    Abstract/FREE Full Text
19. 19.↵
    1. Hill MD,
    2. Rowley HA,
    3. Adler F,
    4. et al

    . Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 2003;34:1925–31

    Abstract/FREE Full Text
20. 20.↵
    1. Molina CA,
    2. Alexandrov AV,
    3. Demchuk AM,
    4. et al

    . Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke 2004;35:151–56

    Abstract/FREE Full Text
21. 21.↵
    1. Machumpurath B,
    2. David SM,
    3. Yan B

    . Rapid neurological recovery after intravenous tissue plasminogen activator in stroke: prognostic factors and outcome. Cerebrovasc Dis 2011;31:278–83

    CrossRefPubMed
22. 22.↵
    1. Machi P,
    2. Costalat V,
    3. Lobotesis K,
    4. et al

    . Solitaire FR thrombectomy system: immediate results in 56 consecutive acute ischemic stroke patients. J Neurointerv Surg 2012;4:62–66

    Abstract/FREE Full Text
23. 23.↵
    1. Castano C,
    2. Dorado L,
    3. Guerrero C,
    4. et al

    . Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 2010;41:1836–40

    Abstract/FREE Full Text
24. 24.↵
    1. Roth C,
    2. Papanagiotou P,
    3. Behnke S,
    4. et al

    . Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke 2010;41:2559–67

    Abstract/FREE Full Text